September 1, 2017Acorda Therapeutics Inc • March 9th, 2018 • Biological products, (no disgnostic substances) • New York
We are delighted to present this letter agreement, setting out the terms of your continued employment with Acorda Therapeutics, Inc. (the "Company") as Chief Technology Officer and Site Head. If these terms are acceptable, please sign and date the copy of this letter provided herewith and return it to me at your first convenience. If you accept the terms offered herein, this Agreement shall be deemed to be effective as of September 1, 2017 (the "Effective Date"). We note that you previously entered into an employment agreement with Civitas Therapeutics, Inc. (“Civitas”), a wholly-owned subsidiary of the Company, and upon the Effective Date the existing Civitas employment agreement will terminate and be superseded in its entirety by this letter agreement.
